Metabolite details
Reactome pathways
- No Reactome pathways listed for this metabolite.
Observed in studies
- Anti-anemia drug FG4592 retards the AKI to CKD transition by improving vascular regeneration and anti-oxidative capability (day 21)
- Anti-anemia drug FG4592 retards the AKI to CKD transition by improving vascular regeneration and anti-oxidative capability (day 10)
- Long-term low-dose ionizing radiation induced chromosome-aberration-specific metabolic phenotype changes in radiation workers